Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice Medscape 20:34 1 month ago 9 Скачать Далее
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference Total Health | Oncology 25:20 1 year ago 2 144 Скачать Далее
Clinical outcomes in women with metastatic HER2-low breast cancer in the real world VJOncology 1:17 2 years ago 191 Скачать Далее
Efficacy of trastuzumab deruxtecan in HER2-low metastatic breast cancer VJOncology 1:05 1 day ago 17 Скачать Далее
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer PeerView Oncology 1:25:22 1 year ago 2 273 Скачать Далее
Research finds undergoing double mastectomy may not improve breast cancer survival CBS Boston 0:55 2 days ago 237 Скачать Далее
Questions remaining in the field of HER2-low breast cancer VJOncology 1:33 1 year ago 531 Скачать Далее
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis ecancer 2:30 1 year ago 199 Скачать Далее
Understanding HER2-Low Breast Cancer: New Insights and Treatment Options Sagely Health - For Cancer Patients. 29:29 8 months ago 876 Скачать Далее
DESTINY-Breast04: A ground-breaking trial in HER2-low breast cancer VJOncology 1:08 2 years ago 187 Скачать Далее
Antibody-Drug Conjugates for HER2-Low Disease: 2023 KU Breast Cancer Year in Review Total Health | Oncology 2:06 1 year ago 92 Скачать Далее
Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer | NEJM NEJM Group 2:12 2 years ago 7 092 Скачать Далее
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton OncBrothers: Practice-Changing Cancer Discussions 22:08 1 month ago 2 474 Скачать Далее